1. Adenylate cyclase (EC 4.6.1.1) activity was characterized in human liver, and its subcellular distribution compared with that of three other potential enzyme markers of the pericellular membrane: leucine aminopeptidase (EC 3.4.1 l.l), yglutamyltransferase (EC 2.3.2.2) and 5'-nucleotidase (EC 3.1.3.5). Although these three enzyme activities were detected in each of the subcellular fractions studied, 85% of the total adenylate cyclase activity was found in the 1OOO g pellet ('nuclear' fraction) with a threefold increase in specific activity as compared with the homogenate. No adenylate cyclase activity existed in the 150 OOO g supernatant fraction.
1. Adenylate cyclase (EC 4.6.1.1) activity was characterized in human liver, and its subcellular distribution compared with that of three other potential enzyme markers of the pericellular membrane: leucine aminopeptidase (EC 3.4.1 l.l), yglutamyltransferase (EC 2.3.2.2) and 5'-nucleotidase (EC 3.1.3.5). Although these three enzyme activities were detected in each of the subcellular fractions studied, 85% of the total adenylate cyclase activity was found in the 1OOO g pellet ('nuclear' fraction) with a threefold increase in specific activity as compared with the homogenate. No adenylate cyclase activity existed in the 150 OOO g supernatant fraction.
2. In the 'nuclear' fraction, adenylate cyclase activity was increased in a dosedependent fashion by glucagon with a half-maximal stimulation at 10 nmol/l and a maximal four-to seven-fold increase at 1 pmol/l. Catecholamines activated adenylate cyclase 2.5-to three-fold, with an order of potency (protokylol > isoprenaline > adrenaline > noradrenaline) typical of a &adrenoreceptor. Prostaglandin E, and NaF also stimulated cyclase twoand four-fold respectively. Insulin, serotonin, dopamine, thyroid-stimulating hormone and ACTH had no effect. Adenosine provoked a weak inhibition at 0.1 mmol/l. Finally guanosine triphosphate and 5'-guanylyl imidodiphosphate induced a marked increase in basal activity, four-and
Introduction
Although the kinetic parameters of hepatic adenylate cyclase from various experimental animals, particularly the rat, have been extensively studied, only a few investigations of the human liver system have been reported (Scott, 1970; Menon, Giese & Jaffe, 1973; Israelsson, Berglung, Ljungqvist & Malmquist, 1978) . Most data were obtained in rat liver from purified plasma membrane preparations in which ten-to 20-fold increases in specific activity were obtained (Pohl, Birnbaumer & Rodbell, 1971; Hanoune, Lacombe & Pecker, 1975) .
In contrast to other classical membrane markers, hormone-sensitive adenylate cyclase requires the integrity of the pericellular membrane, and its activity has already been shown to be influenced in rat liver development (Christoffersen, Morland, Osnes & Bye, 1973; Sicard & Aprille, 1977) , ageing (Kalish, Katz, Pineyro & Gregerman, 1977) and carcinogenesis (Lacombe, Rene, Guellaen & Hanoune, 1976) . Alterations of adenylate cyclase have also been reported during pathological dysfunction of many other tissues (Orgiazzi, Williams, Chopra & Solomon, 1976; Buchwald, 1976; Kim, Frohnert, Hui, Barnes, Farrow & Dousa, 1977; Kiing, Bechtel, Geyer, Salokangas, Preisz, Huber, Torhorst, Jungmann, Talmadge & Epperberger, 1977; Lee, Grollman, Aloj, Kohn & Winand, 1977) . It is therefore tempting to consider that modifications of adenylate cyclase might indeed appear as a valuable criterion of alterations in the pericellular membrane during liver disease.
Because of the very limited amount of tissue available, it is not possible routinely to study the human liver cyclase in a purified plasma membrane preparation. We report here that adenylate cyclase can be assayed in a particulate fraction from human liver with a three-to five-fold increase in specific activity as compared with the homogenate. We characterized the basic properties of the enzyme and compared its subcellular distribution with that of three other membrane enzymes, namely leucine aminopeptidase, y-glutamyltransferase and 5'-nucleotidase. We also investigated the adenylate cyclase system in foetal and cirrhotic human liver.
Experimental procedure

Materials
Porcine crystalline insulin and glucagon were purchased from Novo Laboratories; protokylol (Lakeside), tazolol (Syntex), prostaglandin El (Upjohn), 1-24ACTH (Ciba Geigy), bovine TSH (NIH, Bethesda) and porcine secretin (Dr Mutt, Karolinska Institute, Stockholm) were obtained as gifts. (-)Adrenaline, (-)isoprenaline, (-)noradrenaline, dopamine, AMP, cyclic AMP, adenosine, GTP, L-leucine-p-naphthylamine (Sigma), ATP, 5'-guanylyl imidodiphosphate [Gpp(NH)p], L-yglutamyl-p-nitroanilide (Boehringer-Mannheim), serotonin and glycylglycine (Calbiochem) were from the commercial sources indicated. All other chemicals were from Merck (Darmstadt) and of analytical grade. [u-~*PIATP (0.5-10 Ci/mmol) was obtained from The Radiochemical Centre (Amersham) and cyclic [3-3H]AMP (13 Ci/mmol) was from the CEA (Saclay, France).
Source of liver biopsies
Liver wedge biopsies were obtained from 18 subjects undergoing upper abdominal surgery. Ten subjects (two males, eight females) were free of hepatic abnormalities and eight patients (four males, four females) had histologically proved cirrhosis. The ages were 20-67 (median: 45) years in the patients with no liver disease, and 37-60 (median: 49) years in the patients with cirrhosis. The cause of cirrhosis was alcoholic in seven patients and post-hepatitic in the remaining one. No patient had ascites or encephalopathy at the time of surgery. The same anaesthetic protocol was used in all patients and consisted of thiopental, succinylcholine, pancuronium bromide and phenoperidine. Anaesthesia was maintained with nitrous oxide/ oxygen (2 : 2, v/v). Liver biopsy took place at the beginning of the operation and the specimen was cut into two pieces, one for routine lightmicroscopy examination and the other, immediately transferred at -8OoC, for enzyme study. It was verified, with rat liver, that neither the enzyme activities nor enzyme distributions were modified after the samples had been frozen. Several frozen samples gave similar results, and no change in the enzyme activities studies was observed after up to 4 weeks in the frozen state.
Livers were also obtained from four human foetuses (gestational age, 12-16 weeks) aborted for socio-medical reasons. Foetal livers were processed in a manner similar to the biopsies from adult liver.
Enzyme preparations
All steps were performed at 4OC. For the routine assay of adenylate cyclase activity, a 1500 g pellet fraction was used. The liver fragment (100-200 mg) was minced with scissors and homogenized for 3 x 10 s in 6 vol. of Tris/HCl (50 mmol/l), pH 7.6, in a high-speed mechanical homogenizer (Ultraturrax, Janke and Kunkel, Staufen, Germany). The homogenate was then filtered through two layers of cheesecloth and centrifuged at 1500 g for 15 min. The pellet was resuspended in 1-1.5 ml of the same buffer, and used as the source of adenylate cyclase activity.
For the study of the subcellular distribution of various enzyme activities, we used a larger liver fragment (0.4 9). It was homogenized in 2.5 ml of Tris/HCl (50 mmol/l), pH 7.6, and centrifuged at lo00 g for 10 min for sedimenting the 'nuclear' pellet; the supernatant was. centrifuged at 10 000 g for 15 min in the rotor SS 34 of a Sorvall centrifuge to isolate the 'mitochondrial' fraction. Finally, the 'microsomal' fraction was separated from the cytosolic supernatant by centrifugation at the maximal speed in a rotor Ti 50 of a Beckman Spinco centrifuge L3-50 for 1 h. All fractions were prepared just before measurement of enzyme activities.
Plasma membrane preparation
A plasma membrane preparation was obtained from a 40 g sample of frozen liver obtained from an organ donor according to the procedure devised by Neville (1968) for rat liver, up to step 11. This procedure has been used successfully to obtain purified plasma membrane from mouse (Benedetti & Emmelot, 1968) and guinea pig liver (Coleman & Finean, 1966; Lauter, Solyom & Trams, 1972) but did not give satisfactory results in rabbit or cat (Lauter er al., 1972) . In our preparation, a ten-to 20-fold purification of membrane enzyme markers was achieved in human liver with this procedure. This value is similar to that obtained in rat liver and is close to the theoretical maximal, 33-fold, purification (assuming that plasma membrane proteins comprise approximately 3% of all cellular proteins). However, unlike the rat liver preparation, the plasma membrane prepared from human liver, when examined by electron microscopy, still appeared contaminated by nuclei and other subcellular organelles.
Assay of enzyme activities
Adenylate cyclase (EC 4.6.1.1) activity. This was measured as previously described (Hanoune et al., 1975) . The assay medium contained [ d 2 P I -ATP (lo6 c.p.m., 0.5 mmol/l), MgCI, (3 mmol/l), EDTA (1 mrnol/l), cyclic AMP (1 mmol/l), Tris/HCl (50 mmol/l), pH 7.6, an ATPregenerating system consisting of phosphocreatine (25 mmol/l) and creatine kinase (1 g/l), and 50-100 iig of enzyme fraction protein, in a final volume of 60 d. Incubation was initiated by addition of the enzyme fraction, performed for 10 min at 3OoC and terminated thereafter by a modification of White's (1974) procedure. Results are expressed as pmol of cyclic AMP formed min-I mg-I of protein.
The results obtained from triplicate determinations agreed within 5%.
5'-Nucleotidase (EC 3.1.3.5) activity. This was measured by incubating 0.2-1.0 mg of enzyme protein for 30 min at 37OC in a final volume of 1 ml of Tris/HCl (50 mmol/l), pH 9, containing AMP (5 mmol/l), MgCI, (10 mmol/l) and glycerophosphate (12 mmol/l) to inhibit alkaline phosphatase (Befield & Goldberg, 1968) . Duplicate assays were performed in the absence of AMP.
Reaction was terminated by addition of 1 ml of trichloroacetic acid (100 g/l). After centrifugation, 1 ml aliquots of the supernatant were analysed for liberated inorganic phosphate by the method of Fiske & Subbarow (1925) . 5'-Nucleotidase activity was calculated as the difference between the activities in the presence and absence of AMP. In the different fractions AMP hydrolysis by 5'-nucleotidase represented 50-7096 of total AMP hydrolysis. It was increased to 80% in membrane preparations. Results are expressed as nmol of liberated inorganic phosphate min-I mg-I of protein.
Leucine aminopeptidase (EC 3.4.1 1.1) activity. This was measured in optimal conditions for membrane enzyme activity, as defined by Mahadevan & Tappel (1967) : 20-100 pg of enzyme protein was incubated at room temperature for 10 min in a total volume of 0.3 ml of Tris/HCl (50 mmol/l), pH 7.4, containing CoCl,
(1 mmol/l); 0-1 ml of pchloromercuribenzoate (1 mmol/l) in Tris/HCl (50 mmol/l), pH 7.6, was added and the incubation continued for 10 more min. Finally, 0.1 ml of L-leucyl-Pnaphthylamide (0.5 mmol/l) was added and the mixture incubated at 37OC for 10 min. Incubation was terminated by addition of 2 ml of borate buffer (0.1 mol/l), pH 10.7. The liberated p-naphthylamine was determined with w Eppendorf fluorimeter (Exc. 330 nm; Em: 400-3000 nm). Results are expressed as nmol of liberated p-naphthylamine min-I mg-I of protein.
y-Glutamyltransferase (EC 2.3.2.2) activity. This was determined according to the method of Orlowski & Meister (1965) using pglutamyl-pnitroanilide as substrate. The assay medium, in a final volume of 1 1 ml, consisted of Tris/HCl (100 mmol/l), pH 8.3, glycylglycine (40 mmol/l), yglutamyl-p-nitroanilide (2.5 mmol/l) and 5-50 fig of enzyme protein. Duplicate assays were performed with reduced glutathione (10 mmol/l), which acts as a competitive inhibitor of y-glutamyltransferase activity when assayed as described above. After 10 rnin incubation at 3OoC the reaction was terminated by addition of 1 ml of acetic acid (1-5 mol/l); the assay mixture was then filtered through a glass-fibre filter (Whatman GF/F), and the absorbance of the filtrate was measured at 405 nm against a reference solution containing the same components except that the enzyme fraction was added after addition of acetic acid. The amount of p-nitroaniline formed was calculated according to its molar absorption coefficient (9980 litre mol-I cm-I). y-Glutamyltransferase activity was calculated as the difference between the activities in the absence and presence of reduced glutathione. In the different fractions, unspecific hydrolysis of yglutamyl-p-nitroanilde represented 36% of total yglutamyl-p-nitroanile hydrolysis in supernatant and 20% in other fractions. It was only 10% in membrane preparation. Results are expressed as nmol of p-nitroaniline formed min-I mg-I of protein.
Protein. This was estimated by the Lowry, Rosebrough, Farr & Randall (195 1) procedure with bovine serum albumin as standard.
Results
Subcellular distribution of adenylate cyclase, 5'-nucleotidase, y-glutamyltransferase and leucine aminopeptidase in human liver
Homogenate of human liver was submitted to quantitative fractionation by differential centrifugation. Four fractions were obtained: a nuclear fraction (1000 g pellet), a mitochondrial fraction (10 000 g pellet), a microsomal fraction (150 OOO g pellet) and a cytosol supernatant. In Table 1 are listed the activities and recoveries obtained in the fractionation for the four enzymes studied. The corresponding distribution profiles are depicted in Fig. 1 , according to the representation of AmarCostesec, Beaufay, Wibo, Thines-Sempoux, Feytmans, Robbi & Berthet (1974) . Each enzyme studied gave a distinct pattern of distribution. Glucagon-sensitive adenylate cyclase was present essentially in the nuclear fraction (85% of total activity), with a relative specific activity approaching 3. No activity was detected in cytosol and very little in the other particulate fractions. In contrast, the 'nuclear', 'mitochondrial', 'microsomal' and cytosolic fractions contained 46,29, 10 and 15% of total 5'-nucleotidase activity and 52, 24, 19 and 5% of total y-glutamyltransferase activity respectively. Leucine aminopeptidase had a distribution relatively similar to that of adenylate cyclase, since 62% of total activity was recovered in the 'nuclear' pellet, although a significant fraction of its activity was found in the cytosol ( 10%).
A 1500 g pellet was used for further purification and characterization of adenylate cyclase activity, as described in the next section.
Characterization of adenylate cyclase
Under standard assay conditions, formation of cyclic AMP in a particulate fraction from human liver was found to be linear with respect to protein concentration up to 400 pg of protein/assay. It was also linear with time, up to 15 min of incubation; a 3 min lag phase was observed only in the response to adrenaline (data not shown). A similar finding was previously observed in rat liver plasma membrane (Hanoune et al., 1975) . Finally, a study of adenylate cyclase activity as a function of substrate concentration (Mg-ATP) was performed, under the optimal conditions recommended by Cleland (1970) and already discussed in a previous report (Hanoune et al., 1975) , namely with a constant excess of Mg2+ over the concentration of ATP, at all concentrations of ATP tested (Mg2+ = ATP + 3 mmol/l). Under these conditions and at 
2.
1 - Cyclase activation by catecholamines: nature of the adrenergic receptor Adrenaline (50 pnolll) yielded a twofold increase in enzyme activity (Fig. 3) . The action of various adrenergic agonists was tested in a dosedependent fashion (Fig. 3) . They brought about maximal activation in relation to their affinity for the system. The relative order of potency was: protokylol > isoprenaline > adrenaline > noradrenaline, with corresponding apparent EC,, values of 0-03,0.05,0.5 and 4.0 pnol/l (EC,, = concentration of agonist which caused 50% of maximal activation); the corresponding maximal activation values were 130, 150, 170 and 200% over basal activity respectively. This order of potency is typical of a /?,-adrenoreceptor and is similar to the one found in rat liver (Lacombe et al., 1976) .
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Adenylate c y c h e in human liver
The effect of adrenergic antagonists was also tested. This test was conducted in the presence of a concentration of isoprenaline (0.5 pmolll) which resulted in a submaximal response. The antagonists used were propranolol and tazolol (Vauquelin, Lacombe, Guellaen, Strosberg & Hanoune, 1976 Various concentrations of Mg2+ and ATP were used so that final Mg2+ concentration was always in excess of that of ATP by 3 mmol/l. The data are plotted according to the representation of Hanes; v (adenylate cyclase activity) is expressed as pmol of cyclic AMP formed min-I mg-' of protein; s is Mg-ATP concentration (mmoM).
practolol, a specific PI-adrenoreceptor blocker. The relative order of potency of the lI-adrenoreceptor antagonists is depicted in Fig. 4: propranolol > tazolol > butoxamine > practolol, with corresponding apparent IC,, of 0.04, 3-0, 32 and 440 pnol/l (ICs0 = concentration of antagonist which caused 50% of maximal inhibition). Phentolamine, an a-adrenergic antagonist, had no effect. These results confirm that activation of adenylate cyclase in human liver by adrenergic agonists occurs through P,-adrenoreceptors. As already observed in other systems, catecholamines produced, at low concentrations (1-10 nmol/l), a small but reproducible inhibition of basal enzyme activity (Fig. 3) . As already discussed by Boyd & Martin (1976), the order of potency of the various catecholamines in inhibiting adenylate cyclase, i.e. noradrenaline > adrenaline > isoprenaline, would characterize an a-adrenoreceptor-mediated effect. This phenomenon was not studied further in detail.
Effect of glucagon and of other polypeptide hormones
As expected, human liver cyclase was found highly sensitive to low concentrations of glucagon (Fig. 5) . Enzyme activity increased as a function of glucagon concentration, over a range from 1 nmol/l to 1 pmol/l, with half-maximal stimulation occurring at about 10 nmol/l. Maximal enzyme activation (four-to seven-fold) was obtained in the presence of glucagon (0.5 pmol/l). Secretin (1 ,umoI/l), 1-24ACTH (1 pmol/l) and TSH (20 units/l) had no effect. Insulin, at concentrations from 0.025 to 5 units/l, did not influence the enzyme activity, assayed in the presence or in the absence of glucagon or adrenaline. Finally, prostaglandin E, (10 pmol/l) brought about a 2-5-fold activation of enzyme activity (Table 5 ).
Action of sodium fluoride, guanine nucleotides and adenosine
Similar to all other mammalian cyclase systems, adenylate cyclase from human liver was activated by fluoride: a fourfold increase was observed in the presence of NaF at 10 mmol/l ( in a synergistic manner with hormones. In human liver, basal adenylate cyclase was stimulated in the presence of GTP at 10 pmol/l and Gpp(NH)p at 100 pnol/l, four-and seven-fold respectively ( Table 2 ). The stronger effect of Gpp(NH)p is probably due to its greater lesistance to hydrolysis by nucleotidases. Yet we found no synergy of these nucleotides with either glucagon or adrenaline (Table 2) . On the contrary, the relative stimulation by either hormone was considerably reduced in the presence of guanine nucleotides. Various physiological effects of adenosine have been known for a long time. In several tissues, adenosine stimulates the formation of cyclic AMP. Paradoxically, it has also been shown to inhibit cyclic AMP accumulation in certain tissues and to have both effects in others (Londos & Wolff, 1977;  Malbon, Hert & Fain, 1978) . Israelsson et al. (1978) reported that in the presence of MnCI, at 4 mmol/l, adenosine (0-1 mmol/l) induced a 44% decrease in the glucagon-Gpp(NH)p-stimulated activity. We found that adenosine, at this concentration, in the presence of MgCI, (10 mmol/l) in the assay medium, induced a 30% inhibition of both basal and glucagon-stimulated activities (Table 3) the concentration of Mg2+ was reduced below 3 mmol/l, the inhibitory effect was no longer observed (data not shown).
Adenylate cyclase activity in a pur$ed membrane preparation from human liver
The preparation of the plasma membrane, according to Neville's (1 968) procedure, yielded 0.50 mg of membrane protein/g wet weight of liver. This is less than the value obtained in rat liver (0.8-1-0 mg of membrane protein/g of liver). The purity of our plasma membrane preparation was verified by electron microscopy and by assay of marker enzymes. Bile canaliculi structures, which unequivocally originate from plasma membrane of hepatic parenchyma cells, were found in our preparation, but other subcellular fragments such as nuclei and lipofuscin were also present. Table 4 summarizes the purification of basal, adrenaline-, glucagon-and fluoride-stimulated adenylate cyclase activities in the 1500 g pellet and in the partially purified membrane preparation as compared with liver homogenate results. The activities of three other classical plasma membrane markers, 5'-nucleotidase, leucine aminopeptidase and y-glutamyltransferase are also indicated. These three enzymes were purified 1 1-, 12-and seven-fold respectively, in the membrane preparation with respect to total homogenate. Basal and adrenalinestimulated cyclase activities were enriched 1 1 -fold in the plasma membrane. A 20-fold increase in specific activity was observed for glucagon-and fluoride-stimulated enzyme. The relative stimulation of cyclase by glucagon of NaF was therefore much larger in the purified preparation than that obtained in liver homogenate, a situation which has also been reported in rat liver (Pohl et al., 1971; Hanoune et al., 1975) . Sensitivity to Tm~e 4. Activities of membrane marker enzymes in normal human liver homogenate, 1500 gpellet and membranes Assay conditions were as described in the Experimental procedure section. Adenylate cyclase activity is expressed as pmol of cyclic AMP formed min-l mg-l of protein; other activities are expressed as nmol of product liberated min-I mg-l of protein. adrenaline disappears in purified preparations of rat liver, probably because of the loss of coupling components (Pecker & Hanoune, 1977 ). In contrast, adrenaline was found still very efficient in purified preparation from human liver ( Table 4) .
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Adenylate cyclase activity in cirrhotic liver
The actions of various effectors on adenylate cyclase were tested in 1500 g pellet fractions from eight cirrhotic livers. In this disease, it must be emphasized that expressing the results/mg of protein may not be optimal since the ratio of fibrous tissue over the hepatocyte mass remains unknown in the sample which is homogenized. In addition, nothing is known about the role of the intrahepatic vascular abnormalities which may modify the access in vivo of an effector to the pericellular membrane. These rese-pations, however, will not influence any possible qualitative alteration of the cyclase in cirrhosis.
Basal, PGE,-and secretin-stimulated adenylate cyclase activities of cirrhotic liver did not differ from those of normal liver (Table 5 ). In contrast, Gpp(NH)p, NaF, glucagon and fiadrenergic agonists were much less effective in stimulating adenylate cyclase from cirrhotic than that from normal liver: respective activations by Gpp(NH)p were four-and five-fold for cirrhotic and normal liver respectively, three-and four-fold in the presence of NaF, three-and four-fold in the presence of glucagon and 2.4-and three-fold in the presence of protokylol. The type of the Padrenoreceptor in cirrhotic liver was characterized from the relative potency of various adrenergic agonists tested at a final concentration of 0.5 ,umol/l . Isoprenaline was more potent (2.5-fold stimulation) than adrenaline (twofold stimulation) and noradrenaline was only slightly effective (1.1-fold stimulation). This order corresponds to a /3*-adrenoreceptor.
Adenylate cyclase system from human foetal liver
The adenylate cyclase system was examined in four foetuses whose ages ranged from 12 to 16 weeks. It was responsive to all the effectors of adult liver system. These include Gpp(NH)p, NaF, glucagon and catecholamines, which produced four-, 5.8-, 4-5-and 2.5-fold activation respectively. It appears that basal and stimulated adenylate cyclase activities in foetal liver were higher than those observed in adult normal liver. From the relative order of potency of the four adrenergic agonists protokylol, isoprenaline, adrenaline and noradrenaline, tested at 0.5 pmolll in the assay medium, the adrenergic receptor was found to be of the /I2 type.
Discussion
In this paper we have characterized adenylate cyclase system from human liver and compared it with other well-known marker enzymes of the pericellular membrane. Whereas the other three enzymes tested, 5'-nucleotidase, y-glutamyltransferase and leucine aminopeptidase were found in all the subcellular fractions obtained, distribution of adenylate cyclase appeared to be unique, since 85% of the cyclase activity found in total liver homogenate was recovered in the lo00 g pellet ('nuclear' fraction), with a threefold enhancement of the glucagon-stimulated cyclase activity as compared with that of the homogenate. No activity was detected in the 150000 g supernatant. In fact, hormone-sensitive adenylate cyclase is probably a most complex multicomponent of the plasma membrane and therefore one of the best markers of membrane structure: it comprises a catalytic moiety at the inner surface of the membrane, various hormonal receptors at the outer surface, and also transducing elements which modulate the hormonal signal across the membranes; among these elements, guanine nucleotide-binding entities (Pfeuffer, 1977; Lad, Welton & Rodbell, 1977) , GTPase activity (Cassel, Levkowitz & Selinger, 1977) and regulatory components that are acceptors for ADP-ribose (Moss, Osborne, Fishman, Brewer, Vaughan & Brady, 1977) are likely to play an important role. Another enzyme, 5'-nucleotidase, has proved to be a useful tool for the characterization of a variety of plasma membrane preparations. This membrane enzyme differs from other 5'-nucleotidase activities found in the homogenate by two features: activation by Mg2+ and an optimal pH of 9; activities found in lysosomes, microsomal fraction and cytoplasm have optimal pH values of 6.5, 7.0 and 6.5 respectively (see Lauter et al., 1972) . The fact that we found 5'-nucleotidase activity in all subcellular fractions tested, under assay conditions which eliminated a possible contamination by alkaline phosphatase, might mean either that the membrane enzyme is readily released during homogenization and/or that 5'-nucleotidase is not an optimal marker for plasma membrane in human liver. Leucine aminopeptidase was assayed under optimal conditions for the membrane-bound form of the enzyme (in the presence of Co2+ and p-chloromercuribenzoate): 60% of the total activity was present in the 'nuclear' fraction but at least 10% of total activity was still present in the cytosol. The presence of leucine aminopeptidase and y-glutamyltransferase in all fractions might also be due to enzyme release from membrane during homogenization and centrifugation steps, all the more since those enzymes are well-known to be solubilized by limited proteolysis (Wacker, Lehky, Vanderhaege & Stein, 1976; Hughey & Curthoys, 1976) .
The 1500 g fraction was always used to further characterize adenylate cyclase from human liver. The preparation procedure is simple and adequate for small biopsies. For each individual liver, we used a 200 mg (wet weight) frozen biopsy; 50 mg would have been sufficient. Human liver adenylate cyclase activity was dependent on time of incubation, protein and Mg-ATP concentrations. In other plasma membrane preparations (Garbers & Johnson, 1975) , in particular from rat liver , nonMichaelis-Menten kinetics of the enzyme have been reported. This could be due to multiple adenylate cyclase systems, or negative co-operative behaviour, or substrate activation, or inhibition by free ATP or direct effects of the ATP-regenerating system on the enzyme (Garbers & Johnson, 1975) . That adenylate cyclase is a membrane-bound enzyme makes it also highly dependent on diffusion processis for substrates, ions and activators, which may render interpretation of kinetic patterns even less easy.
The effect of the various activators that we tested (NaF, guanine nucleotides, glucagon, catecholamines, prostaglandin E,) is similar to that observed in rat liver. With the possible exception of a small inhibition by cadrenergic agonists at low concentration (Fig. 3) , the only compound which consistently inhibited cyclase was adenosine. At a final concentration of 0.1 mmol/l, and in the presence of MgCI, (10 mmol/l), we observed a 30% inhibition of both basal and glucagon-stimulated cyclase activities by adenosine. Similar to previous observations reported in the rat lung, or hepatic or platelet enzymes (Dobson, Rubio & Berne, 1971; Londos & Preston, 1977; Londos & Wolff, 1977) , the inhibitory activity of the nucleoside upon human liver cyclase was highly sensitive to the concentration of bivalent cation in the assay medium. It should be noted that, as discussed by Fain & Shepherd (1977) , the physiological meaning of this inhibition has yet to be proven, all the more since this nucleoside is known to influence cyclic AMP synthesis in opposite ways, depending on the tissue studied.
Insulin, at concentrations ranging from 0.025 to 5 unitsh, failed to alter the basal, glucagon-or adrenaline-stimulated cyclase activity in our human liver preparations. An antagonistic action of insulin upon glucagon stimulation was shown in mouse liver (Hepp, 1971 ), but was not reproducibly found in a particulate preparation of rat liver, and was also absent when studied in a purified plasma membrane preparation from rat liver. It has been reported that the presence of adenosine was necessary for insulin to exert its action (Kiss, 1978 ). We have not tested this possibility in our system.
Glucagon is the most potent physiological stimulating agent of human liver cyclase; this is similar to what is observed in rat liver. In addition, the order of potency of various padrenergic agonists (protokylol > isoprenaline > adrenaline > noradrenaline) defines a &-adrenoreceptor subtype for the adrenergic liver receptor in human liver (Fig. 3) as well as in rat liver. However, the catecholamine responsiveness of human cyclase appears more tightly 'coupled' than that of rat liver. Purified rat liver plasma membranes are not stimulated by adrenaline and require the addition of a cytosolic factor to the assay medium (Pecker & Hanoune, 1977) . In contrast, in human liver, cyclase was still sensitive to adrenaline, even when a purified plasma membrane preparation was used (Table 4) .
Purine nucleotides, particularly GTP and its analogue Gpp(NH)p, activate adenylate cyclase in a variety of tissues and their effects are usually synergic with hormones. In rat liver, basal adenylate cyclase was stimulated by GTP or Gpp(NH)p; the activation obtained in the presence of adrenaline or glucagon and either nucleotide was greater than the sum of the activities due to each individual agent (Hanoune el al., 1975) . In human liver, GTP and Gpp(NH)p brought about the greatest stimulation of the basal adenylate cyclase activity (fbur-and seven-fold stimulation respectively). Conversely, stimulation caused by hormones, adrenaline or glucagon, was not synergistically enhanced by guanine nucleotides. Such an unusually important effect of Gpp(NH)p upon basal adenylate cyclase has been reported in human skeletal muscle (Reddy, Oliver, Festoff & Engel, 1978) and in both human normal and tumoral renal cortex (Kim et al., 1977) .
Several reports have presented evidence of altered plasma cyclic AMP concentration in response to glucagon in patients with liver disease (Davies, Prudhoe & Douglas, 1976; Francavilla, Pansini, Sansone, Albano & Martellotta, 1977) . As apparent from data in Table 5 , the adenylate cyclase systems from patients with cirrhosis exhibited a loss of sensitivity to various effectors, as compared with control; the responses to glucagon, catecholamines, NaF and Gpp(NH)p were 26-35% lower than that of normal liver enzyme. These results are in agreement with the observation of Francavilla, Jones & Starzl(1978) , who reported a decreased responsiveness of hepatic adenylate cyclase to glucagon in a group of end-stage cirrhotic patients. The low response to glucagon in vitro is in accordance with the diminished glycaemic response to exogenous glucagon in cirrhotic patients, which itself is related to hyperglucagonaemia of these patients (Sherwin, Fisher, Bessoff, Snyder, Hendler, Conn & Felig, 1978) .
However, the general decrease of responsiveness to the various effectors, Gpp(NH)p, NaF, catecholamines, reported here in vitro, suggests that hepatic damage may be of importance in determining hepatic sensitivity to hormones in cirrhosis.
Glycogen begins to accumulate in the human foetal liver at approximately week 13 of gestation, although it can be detected in live& from much younger foetuses (Capkova & Jirasek, 1968) . A major assumption in the mammalian foetus has been that the pregnant individual provides requisite substrates and fuels for foetal energy production and assimilation throughout gestation. However, several recent investigations have emphasized the adaptive mechanism available to the foetus in ufero that permits response to maternal starvation. Thus Adam, Schwartz, Rahiala & Kekomaki (1978) demonstrated that isolated mid-term human foetal liver, in the absence of exogenous substrate, released glucose during extreme hypoglycaemia. This glucose production, from glycogen stores, is most probably mediated by the adenylate cyclase system. Glucagon is detectable in human foetuses as early as week 8 of gestation (Assan & Boillot, 1971) . Furthermore, the present study shows that a 12-1 6-week-old human foetal liver possesses an adenylate cyclase system which is not only complete but appears to be even more active than that of normal adult liver.
In conclusion, characterization and assay of basal and hormonally stimulated adenylate cyclase activity in biopsies from human liver is easy and requires little material, which should enable one to characterize further the enzyme in abnormal livers. Membrane markers such as 5'-nucleotidase, yglutamyltransferase and leucine aminopeptidase activities have to be very carefully distinguished from possible contamination by lysosomal 5'-nucleotidase and alkaline phosphatase, by unspecific peptide hydrolases, and by the cytosolic form of leucine aminopeptidase respectively. This makes adenylate cyclase all the more attractive as a simple and reliable plasma membrane marker. Similarities between human and rat liver adenylate cyclase validate the use of the latter as a tool for pharmacological and physiological studies. This is not the case for the fat-cell system, which appears to differ markedly in man and in the rat (Poupon, 1975; Cooper, Partilla & Gregerman, 1976) .
